Advertisement

Skin (Melanoma and Nonmelanoma Skin Cancers)

  • Gregory D. Judy
  • Bhishamjit S. Chera
Chapter

Abstract

Radiation therapy is commonly used to treat nonmelanoma skin cancer (NMSC) and melanoma. Historically there have been a wide range of doses utilized for NMSC, depending on tumor location, age/performance status of patients, desired cosmetic outcome, and presence of high-risk features such as PNI. Melanoma has been thought of as a more radioresistant tumor; however, this thinking is changing based on newer data. This chapter summarizes the use of hypofractionated RT for both NMSC and melanoma in the definitive setting.

Keywords

Skin cancer Melanoma Radiation Hypofractionation SBRT 

References

  1. 1.
    Ballo MT, Burmeister BH. Malignant melanoma. Clinical radiation oncology. 4th ed. Philadelphia: Saunders/Elsevier; 2016. p. 777–87.CrossRefGoogle Scholar
  2. 2.
    Screening and early detection of melanoma. Accessed 25 July 2016.Google Scholar
  3. 3.
    Radiation therapy in the management of melanoma. Accessed 25 July 2016.Google Scholar
  4. 4.
    Veness MJ, Howle J. Cutaneous carcinoma. Clinical radiation oncology. 4th ed. Philadelphia: Saunders/Elsevier; 2016. p. 763–76.CrossRefGoogle Scholar
  5. 5.
    Million RR, Cassisi NJ. Management of head and neck cancer: a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott; 1994.Google Scholar
  6. 6.
    Ang KK, Byers RM, Peters LJ, et al. Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results. Arch Otolaryngol Head Neck Surg. 1990;116:169–72.CrossRefPubMedGoogle Scholar
  7. 7.
    Chang DT, Amdur RJ, Morris CG, Mendenhall WM. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys. 2006;66:1051–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Ballo MT, Ross MI, Cormier JN, et al. Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys. 2006;64:106–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13:589–97.CrossRefPubMedGoogle Scholar
  10. 10.
    Burmeister BH, Mark Smithers B, Burmeister E, et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol. 2006;81:136–42.CrossRefPubMedGoogle Scholar
  11. 11.
    Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys. 2010;37:4078–101.CrossRefPubMedGoogle Scholar
  12. 12.
    Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76:S10–9.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol. 2010;95:245–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Abbatucci JS, Boulier N, Laforge T, Lozier JC. Radiation therapy of skin carcinomas: results of a hypofractionated irradiation schedule in 675 cases followed more than 2 years. Radiother Oncol. 1989;14:113–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Sause WT, Cooper JS, Rush S, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys. 1991;20:429–32.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Gregory D. Judy
    • 1
    • 2
  • Bhishamjit S. Chera
    • 1
    • 2
  1. 1.Department of Radiation OncologyUniversity of North Carolina School of MedicineChapel HillUSA
  2. 2.Lineberger Comprehensive Cancer CenterUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations